- The Hong Kong stock market in Q4 2026 exhibits a clear sectoral divergence, featuring robust performances in logistics and biotech alongside pressures in the consumer sector.
- JD Logistics achieves strong operational resilience through integration and innovation, while innovative biotech firms like Harbor BioMed secure key approvals and funding.
- Meanwhile, hardware companies surge on AI demand, and traditional giants actively restructure strategies amidst market uncertainties.